Relapsed Or Refractory Multiple Myeloma

Multiple Myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, which are white blood cells found in bone marrow. When the cancer progresses, it is referred to as Relapsed Or Refractory Multiple Myeloma (RRMM). RRMM occurs when the cancer has returned either after treatment or has not responded to the initial treatment.

Patients diagnosed with RRMM often face a poorer prognosis and a shorter life expectancy compared to those who are first-time diagnosed.

Common symptoms of RRMM include:

Fatigue
Bone pain
Anemia
Infections
Nausea
Weight loss
Kidney Function impairment
Risk of Compression Fractures of the spine

The treatment of RRMM depends on a variety of factors such as the stage of the cancer, the patient's age, and other health conditions. Treatment options may include:

Chemotherapy
Immunotherapy
Stem Cell Transplant
Targeted Therapies
Radiation Therapy
Surgery

Patients should work closely with a healthcare team to create an individualized treatment plan and to ensure they receive the most appropriate care.